FDA says new regulations are needed to manage CBD risks
The Food and Drug Administration (FDA) on Thursday called for new regulations for the cannabidiol (CBD) market, saying the agency needs to provide additional oversight to manage the risks involved in using those products. Janet Woodcock, the principal deputy commissioner of the FDA, said in a release that the agency ... Read More